Article

Large Scale Profiling of SARS-CoV-2-Infected Patients Identified Potential Therapeutic Host Targets and Drug Candidates for COVID-19

2021-02-18

Abstract excerpt

Given the rapid spread of SARS-CoV-2 and rising death toll of COVID-19 in the current absence of effective treatments, it is imperative that therapeutics are developed and made available to patients as quickly as possible. Publicly available COVID-19 patient data can be used to identify host therapeutic targets, tailoring treatments to the disease signatures observed in patients. In this study, we identify potenti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b40d6c3e-29c4-5a91-8ab9-c028e343076a
DOI: 10.26434/chemrxiv.13660982.v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Large Scale Profiling of SARS-CoV-2-Infected Patients Identified Potential Therapeutic Host Targets and Drug Candidates for COVID-19DOI 10.26434/chemrxiv.13660982.v3Read

Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic dataSemantic proximity Read

RNASeq profiling of COVID19‐infected patients identified an EIF2AK2 inhibitor as a potent SARS‐CoV‐2 antiviralSemantic proximity Read

Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanismSemantic proximity Read

Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 diseaseSemantic proximity Read

Analysis of transcriptomics data from COVID-19 patients: a pilot researchSemantic proximity Read

Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cellsSemantic proximity Read

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: insights from machine learning and bioinformatics approachesSemantic proximity Read

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approachesSemantic proximity Read

Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug ArsenalSemantic proximity Read

Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2Semantic proximity Read

Identification of COVID-19-relevant transcriptional regulatory networks and associated kinases as potential therapeutic targetsSemantic proximity Read

Transcriptomic Signatures and Repurposing Drugs for COVID-19 Patients: Findings of Bioinformatics AnalysesSemantic proximity Read